0000950170-24-052877.txt : 20240503
0000950170-24-052877.hdr.sgml : 20240503
20240503160522
ACCESSION NUMBER: 0000950170-24-052877
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240419
FILED AS OF DATE: 20240503
DATE AS OF CHANGE: 20240503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ATAI Life Sciences AG
CENTRAL INDEX KEY: 0001776242
ORGANIZATION NAME:
STATE OF INCORPORATION: 2M
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-31187
FILM NUMBER: 24912971
BUSINESS ADDRESS:
STREET 1: KRAUSENSTRASSE 9-10
CITY: BERLIN
STATE: 2M
ZIP: 10117
BUSINESS PHONE: 4917632963813
MAIL ADDRESS:
STREET 1: KRAUSENSTRASSE 9-10
CITY: BERLIN
STATE: 2M
ZIP: 10117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ATAI Life Sciences N.V.
CENTRAL INDEX KEY: 0001840904
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-31187
FILM NUMBER: 24912972
BUSINESS ADDRESS:
STREET 1: WALLSTRASSE 16
CITY: BERLIN
STATE: 2M
ZIP: 10179
BUSINESS PHONE: (617)-699-5876
MAIL ADDRESS:
STREET 1: 524 BROADWAY
CITY: NEW YORK
STATE: NY
ZIP: 10013
FORMER NAME:
FORMER CONFORMED NAME: ATAI Life Sciences B.V.
DATE OF NAME CHANGE: 20210115
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IntelGenx Technologies Corp.
CENTRAL INDEX KEY: 0001098880
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 870638336
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6420 ABRAMS
CITY: SAINT LAURENT
STATE: A8
ZIP: H4S 1Y2
BUSINESS PHONE: 514-331-7440
MAIL ADDRESS:
STREET 1: 6420 ABRAMS
CITY: SAINT LAURENT
STATE: A8
ZIP: H4S 1Y2
FORMER COMPANY:
FORMER CONFORMED NAME: BIG FLASH CORP
DATE OF NAME CHANGE: 19991112
4
1
ownership.xml
4
X0508
4
2024-04-19
0001098880
IntelGenx Technologies Corp.
IGXT
0001840904
ATAI Life Sciences N.V.
WALLSTRABE 16
BERLIN
2M
10179
GERMANY
false
false
true
false
0001776242
ATAI Life Sciences AG
WALLSTRABE 16
BERLIN
2M
10179
GERMANY
false
false
true
false
false
Convertible Notes
0.185
2024-04-19
4
J
false
1000000
A
2024-04-19
2026-02-01
Common Stock
5405405
10500000
I
By ATAI Life Sciences AG
On April 19, 2024, pursuant to the Third Amended and Restated Loan Agreement, ATAI AG provided to IntelGenX Corp. an additional term loan in an amount equal to $1,000,000, which is convertible to shares of Common Stock at a price of $0.185 per share. Any accrued interest outstanding under the loan may be converted into shares of Common Stock at the five day volume weighted average price of the shares, less the maximum permitted discount under certain applicable rules, ending on the day that is the second business day before the day the interest becomes due and payable.
Reflects securities held of record by ATAI AG, which is a wholly owned subsidiary of ATAI Life Sciences N.V., and as a result, ATAI Life Sciences N.V. may be deemed to share beneficial ownership over the securities reported herein.
ATAI Life Sciences N.V., By: /s/ Florian Brand, Chief Executive Officer
2024-05-03
ATAI Life Sciences AG, By: /s/ Florian Brand, Chief Executive Officer
2024-05-03